Fortis investors voice concerns over Delhi HC forensic audit order

Domestic and foreign institutional investors in Fortis Healthcare have raised concerns following a Delhi High Court order directing a forensic audit of transactions involving the company's former promoters. The August 31 order emerged from Japanese pharmaceutical firm Daiichi Sankyo's bid to enforce an arbitral award against the erstwhile Fortis promoters. Fortis subsequently filed a special leave petition in the Supreme Court challenging the directive.